Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statins for Stricturing Crohn's Disease
NCT06538649Phase 1Recruiting
- Sponsor
- Stanford University
- Start
- Dec 2024
- Primary completion
- Oct 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised trial of rosuvastatin in Crohn's disease (2 arms), sponsored by Stanford University. Primary endpoint: Rutgeerts score. Started Dec 2024; status: recruiting.
02
Drugs
rosuvastatin
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT06538649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06538649.